Poly(2-ethyl-(2-pyrrolidone) methacrylate) and hyaluronic acid-based hydrogels for the engineering of a cartilage-like tissue using bovine articular chondrocytes

Journal of Bioactive and Compatible Polymers

Volumn 29, Issue 6, 2014, Pages 545-559

  Magalhães, Joana ^a,b   Crawford, Aileen ^c   Hatton, Paul V ^c   Blanco, Francisco J ^b   Roman, Julio San ^a,d  

^a BIOMATERIALES Y NANOMEDICINA CIBER BBN   (Spain)

^b UNIVERSITY OF A CORUÑA   (Spain)

^c UNIVERSITY OF SHEFFIELD   (United Kingdom)

^d INSTITUTO DE CIENCIA Y TECNOLOGÍA DE POLÍMEROS   (Spain)

Author keywords

biocompatibility; cartilage tissue engineering; chondrocytes; hyaluronic acid; Hydrogels

Indexed keywords

ACRYLIC MONOMERS; BIOCOMPATIBILITY; CARTILAGE; CELL PROLIFERATION; CELLS; CROSSLINKING; CYTOLOGY; FREE RADICAL POLYMERIZATION; FREE RADICALS; GLYCOLS; HYDROGELS; MAMMALS; MORPHOLOGY; ORGANIC ACIDS; TISSUE; TISSUE ENGINEERING;

BIOCHEMICAL COMPOSITION; BOVINE ARTICULAR CHONDROCYTES; CARTILAGE TISSUE ENGINEERING; CHONDROCYTES; HYALURONIC ACID HYDROGELS; METHYLENE BISACRYLAMIDE; TISSUE ENGINEERING APPLICATIONS; TRIETHYLENE GLYCOL DIMETHACRYLATE;

HYALURONIC ACID;

2 ETHYL (2 PYRROLIDONE)METHACRYLATE; COLLAGEN TYPE 2; GLYCOSAMINOGLYCAN; HYALURONIC ACID; N,N' METHYLENEBISACRYLAMIDE; POLY(ETHYL METHACRYLATE); TRIETHYLENE GLYCOL DIMETHACRYLATE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CARTILAGE CELL; CATTLE; CELL PROLIFERATION; CELL STRUCTURE; CELLULAR DISTRIBUTION; CROSS LINKING; EXTRACELLULAR MATRIX; HYDROGEL; NONHUMAN; POLYMERIZATION;

EID: 84908897081     PISSN: 08839115     EISSN: 15308030     Source Type: Journal    
DOI: 10.1177/0883911514555609     Document Type: Article

References (54)

1. Ruiz-Romero C, Blanco FJ.. The role of proteomics in osteoarthritis pathogenesis research. Curr Drug Targets. 2009 ; 10 (6). 543-556
2. Lawrence RC, Felson DT, Helmick CG, et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. Arthritis Rheum. 2008 ; 58 (1). 26-35
3. Felson DT, Lawrence RC, Dieppe PA, et al. Osteoarthritis: new insights. Part 1: the disease and its risk factors. Ann Intern Med. 2000 ; 133 (8). 635-646
4. Roos EM.. Joint injury causes knee osteoarthritis in young adults. Curr Opin Rheumatol. 2005 ; 17 (2). 195-200
5. Lohmander LS, Ostenberg A, Englund M, et al. High prevalence of knee osteoarthritis, pain, and functional limitations in female soccer players twelve years after anterior cruciate ligament injury. Arthritis Rheum. 2004 ; 50 (10). 3145-3152
6. Lutzner J, Kasten P, Gunther KP, et al. Surgical options for patients with osteoarthritis of the knee. Nat Rev Rheumatol. 2009 ; 5 (6). 309-316
7. Brittberg M, Lindahl A, Nilsson A, et al. Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. N Engl J Med. 1994 ; 331 (14). 889-895
8. Hangody L, Kish G, Karpati Z, et al. Mosaicplasty for the treatment of articular cartilage defects: application in clinical practice. Orthopedics. 1998 ; 21 (7). 751-756
9. Mithoefer K, McAdams T, Williams RJ, et al. Clinical efficacy of the microfracture technique for articular cartilage repair in the knee: an evidence-based systematic analysis. Am J Sports Med. 2009 ; 37 (10). 2053-2063
10. Bekkers JE, Inklaar M, Saris DB.. Treatment selection in articular cartilage lesions of the knee: a systematic review. Am J Sports Med. 2009 ; 37: 148S - 155S
11. Steinert AF, Ghivizzani SC, Rethwilm A, et al. Major biological obstacles for persistent cell-based regeneration of articular cartilage. Arthritis Res Ther. 2007 ; 9 (3). 213
12. Sittinger M, Burmester GR.. Can engineered cartilage transplants be used for treating rheumatic diseases?. Nat Clin Pract Rheumatol. 2006 ; 2 (4). 172-173
13. Buckwalter JA, Mow VC, Ratcliffe A.. Restoration of injured or degenerated articular cartilage. J Am Acad Orthop Surg. 1994 ; 2 (4). 192-201
14. Mankin HJ.. The response of articular cartilage to mechanical injury. J Bone Joint Surg Am. 1982 ; 64 (3). 460-466
15. Temenoff JS, Mikos AG.. Review: tissue engineering for regeneration of articular cartilage. Biomaterials. 2000 ; 21 (5). 431-440
16. Behrens P, Bitter T, Kurz B, et al. Matrix-associated autologous chondrocyte transplantation/implantation (MACT/MACI) - 5-year follow-up. Knee. 2006 ; 13 (3). 194-202
17. Dehne T, Karlsson C, Ringe J, et al. Chondrogenic differentiation potential of osteoarthritic chondrocytes and their possible use in matrix-associated autologous chondrocyte transplantation. Arthritis Res Ther. 2009 ; 11 (5). R133
18. Kreuz PC, Muller S, Ossendorf C, et al. Treatment of focal degenerative cartilage defects with polymer-based autologous chondrocyte grafts: four-year clinical results. Arthritis Res Ther. 2009 ; 11 (2). R33
19. Podskubka A, Povysil C, Kubes R, et al. Treatment of deep cartilage defects of the knee with autologous chondrocyte transplantation on a hyaluronic acid ester scaffolds (Hyalograft C). Acta Chir Orthop Traumatol Cech. 2006 ; 73 (4). 251-263
20. Andereya S, Maus U, Gavenis K, et al. First clinical experiences with a novel 3D-collagen gel (CaReS) for the treatment of focal cartilage defects in the knee. Z Orthop ihre Grenzgeb. 2006 ; 144 (3). 272-280
21. Nehrer S, Dorotka R, Domayer S, et al. Treatment of full-thickness chondral defects with hyalograft C in the knee: a prospective clinical case series with 2 to 7 years' follow-up. Am J Sports Med. 2009 ; 37: 81S - 87S
22. Bartlett W, Skinner JA, Gooding CR, et al. Autologous chondrocyte implantation versus matrix-induced autologous chondrocyte implantation for osteochondral defects of the knee: a prospective, randomised study. J Bone Joint Surg Br. 2005 ; 87 (5). 640-645
23. Ossendorf C, Kaps C, Kreuz PC, et al. Treatment of posttraumatic and focal osteoarthritic cartilage defects of the knee with autologous polymer-based three-dimensional chondrocyte grafts: 2-year clinical results. Arthritis Res Ther. 2007 ; 9 (2). R41
24. Khan WS, Hardingham TE.. Cartilage tissue engineering approaches applicable in orthopaedic surgery: the past, the present, and the future. J Stem Cells. 2012 ; 7 (2). 97-104
25. Fakhari A, Berkland C.. Applications and emerging trends of hyaluronic acid in tissue engineering, as a dermal filler and in osteoarthritis treatment. Acta Biomater. 2013 ; 9 (7). 7081-7092
26. Borzacchiello A, Gloria A, Mayol L, et al. Natural/synthetic porous scaffold designs and properties for fibro-cartilaginous tissue engineering. J Bioact Compat Polym. 2011 ; 26 (5). 437-451
27. Xin X, Borzacchiello A, Netti PA, et al. Hyaluronic-acid-based semi-interpenetrating materials. J Biomater Sci Polym Ed. 2004 ; 15 (9). 1223-1236
28. Burdick JA, Prestwich GD.. Hyaluronic acid hydrogels for biomedical applications. Adv Mater. 2011 ; 23 (12). H41 - H56
29. Balazs EA, Denlinger JL.. Viscosupplementa-tion: a new concept in the treatment of osteoarthritis. J Rheumatol Suppl. 1993 ; 39: 3-9
30. Barbucci R, Lamponi S, Borzacchiello A, et al. Hyaluronic acid hydrogel in the treatment of osteoarthritis. Biomaterials. 2002 ; 23 (23). 4503-4513
31. Xuejun X, Netti PA, Ambrosio L, et al. Preparation and characterization of a hydrogel from low-molecular weight hyaluronic acid. J Bioact Compat Polym. 2004 ; 19 (1). 5-15
32. Ren Y-J, Zhou Z-Y, Cui F-Z, et al. Hyaluronic acid/polylysine hydrogel as a transfer system for transplantation of neural stem cells. J Bioact Compat Polym. 2009 ; 24 (1). 56-62
33. Rocha PM, Santo VE, Gomes ME, et al. Encapsulation of adipose-derived stem cells and transforming growth factor-γ 1 in carrageenan-based hydrogels for cartilage tissue engineering. J Bioact Compat Polym. 2011 ; 26 (5). 493-507
34. Wei Y-T, Sun X-D, Xue X, et al. Hyaluronic acid hydrogel modified with Nogo-66 receptor antibody and poly(L-Lysine) enhancement of adherence and survival of primary hippocampal neurons. J Bioact Compat Polym. 2009 ; 24 (3). 205-219
35. Magalhães J, Sousa RA, Mano JF, et al. Synthesis and characterization of sensitive hydrogels based on semi-interpenetrated networks of poly[2-ethyl-(2-pyrrolidone) methacrylate] and hyaluronic acid. J Biomed Mater Res A. 2013 ; 101 (1). 157-166
36. Santos JR, Alves NM, Mano JF.. New thermo-responsive hydrogels based on poly (N-isopropylacrylamide)/hyaluronic acid semi-interpenetrated polymer networks: swelling properties and drug release studies. J Bioact Compat Polym. 2010 ; 25 (2). 169-184
37. Crawford A, Dickinson SC Methods in Molecular Biology: Biopolymer methods in tissue engineering. New York, USA: Humana Press ; 2004
38. Kafienah W, Sims TJ Methods in Molecular Biology: Biopolymer methods in tissue engineering. New York, USA: Humana Press ; 2004
39. Farndale RW, Buttle DJ, Barrett AJ.. Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue. Biochim Biophys Acta. 1986 ; 883 (2). 173-177
40. Suri S, Schmidt CE.. Photopatterned collagen-hyaluronic acid interpenetrating polymer network hydrogels. Acta Biomater. 2009 ; 5 (7). 2385-2397
41. Magalhães J, Crawford A, Hatton PV, et al. Mineralization of porous hydrogels based on semi-interpenetrated networks of poly[2-ethyl(2-pyrrolidone) methacrylate] and hyaluronic acid in simulated body fluid. J Bioact Compat Polym. 2013 ; 28 (5). 468-480
42. Almarza AJ, Athanasiou KA.. Design characteristics for the tissue engineering of cartilaginous tissues. Ann Biomed Eng. 2004 ; 32 (1). 2-17
43. Oliveira JT, Crawford A, Mundy JM, et al. A cartilage tissue engineering approach combining starch-polycaprolactone fibre mesh scaffolds with bovine articular chondrocytes. J Mater Sci Mater Med. 2007 ; 18 (2). 295-302
44. Pelttari K, Wixmerten A, Martin I.. Do we really need cartilage tissue engineering?. Swiss Med Wkly. 2009 ; 139 (41-42). 602-609
45. Senköü A, Simsek A, Sahin FI, et al. Interaction of cultured chondrocytes with chitosan scaffold. J Bioact Compat Polym. 2001 ; 16 (2). 136-144
46. Correia CR, Moreira-Teixeira LS, Moroni L, et al. Chitosan scaffolds containing hyaluronic acid for cartilage tissue engineering. Tissue Eng Part C Methods. 2011 ; 17 (7). 717-730
47. Alves da, Silva ML, Crawford A, Mundy JM, et al. Chitosan/polyester-based scaffolds for cartilage tissue engineering: assessment of extracellular matrix formation. Acta Biomater. 2010 ; 6 (3). 1149-1157
48. Zhang Q, Lu H, Kawazoe N, et al. Preparation of collagen scaffolds with controlled pore structures and improved mechanical property for cartilage tissue engineering. J Bioact Compat Polym. 2013 ; 28 (5). 426-438
49. Bryant SJ, Anseth KS.. Hydrogel properties influence ECM production by chondrocytes photoencapsulated in poly(ethylene glycol) hydrogels. J Biomed Mater Res. 2002 ; 59 (1). 63-72
50. Cuggino JC, Igarzabal CIA, Rueda JC, et al. Synthesis and characterization of new hydrogels through copolymerization of N-acryloyl-tris-(hydroxymethyl)aminomethane and different crosslinking agents. Eur Polym J. 2008 ; 44 (11). 3548-3555
51. Kang JY, Chung CW, Sung JH, et al. Novel porous matrix of hyaluronic acid for the three-dimensional culture of chondrocytes. Int J Pharm. 2009 ; 369 (1-2). 114-120
52. Da Silva MA, Crawford A, Mundy J, et al. Evaluation of extracellular matrix formation in polycaprolactone and starch-compounded polycaprolactone nanofiber meshes when seeded with bovine articular chondrocytes. Tissue Eng Part A. 2009 ; 15 (2). 377-385
53. Kutty JK, Cho E, Soo Lee J, et al. The effect of hyaluronic acid incorporation on fibroblast spreading and proliferation within PEG-diacrylate based semi-interpenetrating networks. Biomaterials. 2007 ; 28 (33). 4928-4938
54. Spiller KL, Maher SA, Lowman AM.. Hydrogels for the repair of articular cartilage defects. Tissue Eng Part B Rev. 2011 ; 17 (4). 281-299